
|
Physiologic
basis for hyperlactatemia defined
Changes
in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected
Patients [Cote HCF et al. NEJM 2002;346:811]: The authors
used a novel method to analyze mitochondrial DNA in venous blood
to determine the ratios of mitochondrial:nuclear DNA in three patient
populations: eight HIV-infected patients with symptomatic hyperlactatemia
from nucleosides, 47 HIV-infected patients who were untreated, and
24 controls without HIV infection. The mtDNA:nDNA ratio was reduced
by 68% in those with hyperlactatemia compared to controls and reduced
by 43% compared to untreated HIV-infected patients. With discontinuation
of nucleosides the half-life of mitochondrial DNA ranged from 4.5
to 8 weeks and the time required for lactate levels to return to
normal range was 4-28 weeks. The authors conclude that mitochondrial
DNA levels are significantly reduced in patients with symptomatic
hyperlactatemia due to nucleosides and that these changes resolve
when treatment is discontinued.
Comment: It
has been previously shown that nucleoside analogs inhibit DNA polymerase
gamma leading to depletion of mitochondria DNA and that this appears
to be the cause of lactic acidosis, hepatic steatosis, myopathy,
cardiomyopathy, peripheral neuropathy, pancreatitis, and possibly
lipoatrophy. Hyperlactatemia appears to be the result of mitochondrial
toxicity (Nat Med 1995;1:417; JCI 1995;96:126) and is most common
in patients receiving stavudine (CID 2000;31:162; CID 2001;33:2072;
AIDS 2001;15:717). In the present study all eight of the patients
with hyperlactatemia had received stavudine for 33-192 weeks. An
important advance in this study was the method to assay mitochondrial
DNA. The standard method requires a muscle or liver biopsy, which
is obviously impractical for general application. In this study
the test was done on venous blood with quantification of nuclear
gene and mitochondrial gene by PCR. The authors point out that in
inherited mitochondrial diseases, severe symptoms occur when levels
of mitochondrial DNA are reduced to 20% of normal, which is similar
to the depletion observed in symptomatic patients in this study.

|

|